See more : Hércules S.A – Fábrica de Talheres (HETA4.SA) Income Statement Analysis – Financial Results
Complete financial analysis of Emplicure AB (publ) (EMPLI.ST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Emplicure AB (publ), a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- DXN Limited (DXN.AX) Income Statement Analysis – Financial Results
- Laurus Labs Limited (LAURUSLABS.NS) Income Statement Analysis – Financial Results
- Filatex Fashions Limited (FILATFASH.BO) Income Statement Analysis – Financial Results
- Tanabe Engineering Corporation (1828.T) Income Statement Analysis – Financial Results
- Rupert Resources Ltd. (RUPRF) Income Statement Analysis – Financial Results
Emplicure AB (publ) (EMPLI.ST)
About Emplicure AB (publ)
Emplicure AB (publ) engages in the research and development of pharmaceutical products primarily for the treatment of chronic pain in Sweden. The company provides Empli03, an oral buccal tablet; and Amp01, an oral nicotine pouches. Emplicure AB (publ) was incorporated in 2014 and is based in Uppsala, Sweden.
| Metric | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|
| Revenue | 1.12M | 80.00K | 290.34K | 104.17K |
| Cost of Revenue | 6.09M | 406.00K | 3.25M | 0.00 |
| Gross Profit | -4.97M | -326.00K | -2.96M | 104.17K |
| Gross Profit Ratio | -442.87% | -407.50% | -1,018.00% | 100.00% |
| Research & Development | 0.00 | 406.00K | 0.00 | 0.00 |
| General & Administrative | 0.00 | 10.69M | 3.25M | 2.42M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 23.65M | 10.69M | 3.25M | 2.42M |
| Other Expenses | 23.78M | 5.66M | 1.65M | 2.85M |
| Operating Expenses | 23.78M | 16.35M | 4.90M | 5.27M |
| Cost & Expenses | 29.87M | 16.75M | 4.90M | 5.27M |
| Interest Income | 36.00K | 21.00K | 874.00 | 7.82K |
| Interest Expense | 299.00K | 1.76M | 202.00 | 171.00 |
| Depreciation & Amortization | 732.00K | 33.00K | 874.00 | 7.81K |
| EBITDA | -29.14M | -16.64M | -4.61M | -5.15M |
| EBITDA Ratio | -2,596.79% | -20,800.00% | -1,587.23% | -4,947.54% |
| Operating Income | -29.87M | -16.67M | -4.61M | -5.16M |
| Operating Income Ratio | -2,662.03% | -20,841.25% | -1,587.53% | -4,955.04% |
| Total Other Income/Expenses | 363.00K | -1.74M | 672.00 | 7.64K |
| Income Before Tax | -29.51M | -18.42M | -4.61M | -5.15M |
| Income Before Tax Ratio | -2,629.68% | -23,018.75% | -1,587.30% | -4,947.71% |
| Income Tax Expense | -363.00K | 1.76M | -672.00 | -7.64K |
| Net Income | -29.14M | -20.18M | -4.61M | -5.15M |
| Net Income Ratio | -2,597.33% | -25,222.50% | -1,587.07% | -4,940.37% |
| EPS | -1.20 | -1.27 | -0.34 | -0.47 |
| EPS Diluted | -1.20 | -1.27 | -0.34 | -0.47 |
| Weighted Avg Shares Out | 24.20M | 15.92M | 13.40M | 10.96M |
| Weighted Avg Shares Out (Dil) | 24.20M | 15.92M | 13.40M | 10.96M |
Source: https://incomestatements.info
Category: Stock Reports